Entering text into the input field will update the search result below

Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag

Mar. 28, 2023 3:20 PM ETVanda Pharmaceuticals Inc. (VNDA)By: Jonathan Block, SA News Editor

Freedom of information act FOIA written in business law textbook

Jon Frederick/iStock via Getty Images

  • A federal court judge has ruled that Vanda Pharmaceuticals should have access to documents related the the US FDA's review of a supplemental jet lag indication for its drug Hetlioz (tasimelteon).
  • The FDA issued

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About VNDA

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Vanda Pharmaceuticals Inc.
Repare Therapeutics Inc.
Innate Pharma S.A.
Cellectis S.A.
Enanta Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.